The European Association of Euro-Pharmaceutical Companies (EAEPC) is a Brussels-based non-profit making organisation, which regroup the European licensed parallel distribution industry, championing the industry's achievements and the benefits of its products.
Through national associations and individual company membership, it encompasses over 80 firms from 23 countries in the European Economic Area (EEA). All products handled by EAEPC members have national or EU regulatory approval and are exclusively sourced from and sold to EEA countries using authorised trade channels.
One of the goals of EAEPC is to safeguard the free movement of medicines, as laid down in Article 28 EC, and to counteract any attempts to restrict the freedom of choice for the consumer through trading patterns in breach of Articles 81 EC Treaty & 82 EC Treaty. The Association believes that free trade will lead to improvements in health standards through the provision of innovative medicines at lower cost, benefiting statutory healthcare systems, other third-party payers, and the public as both patients and taxpayers, as well as assisting the EU to achieve its objective of a single, internal market.